Related Experiment Video
Updated: Jul 1, 2026
A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level
Published on: January 19, 2024
Characterization and differentiation of iron status in anemic very low birth weight infants using a diagnostic
David C Kasper1, John A Widness, Nadja Haiden
1Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria. david.kasper@meduniwien.ac.at
Insights
A diagnostic plot effectively differentiates iron status in anemic very low birth weight (VLBW) infants treated with erythropoietin (EPO) and iron. This tool aids in assessing iron availability and demand for erythropoiesis in VLBW infants.
Area of Science:
- Neonatal Medicine
- Pediatric Hematology
- Clinical Diagnostics
Background:
- Very low birth weight (VLBW) infants frequently develop anemia due to frequent blood sampling.
- Red blood cell transfusions are common, but treatment with erythropoietin (EPO) and iron is debated.
- Optimal dosing strategies for EPO and iron in VLBW infants remain uncertain.
Purpose of the Study:
- To evaluate a four-quadrant diagnostic plot for assessing iron status in anemic VLBW infants.
- The plot analyzes iron availability (ferritin index) against iron demand for erythropoiesis (reticulocyte hemoglobin content, CHr).
Main Methods:
- Utilized data from a randomized controlled trial involving VLBW infants (<31 weeks gestation, <1,300 g).
- Infants received 18 days of treatment: oral iron alone, EPO + oral iron, or EPO + intravenous + oral iron.
Main Results:
- Both EPO treatment groups showed significantly higher ferritin indices compared to the control group.
- The control group's CHr indicated functional iron deficiency and anemia of chronic disease by day 18.
- EPO-treated groups demonstrated latent iron deficiency and iron deficiency anemia patterns.
Conclusions:
- The diagnostic plot appears to be a useful clinical tool for assessing iron status in VLBW infants under various erythropoietic conditions.
- Further research in complex patient populations is necessary to confirm the diagnostic procedure's clinical utility.
Background:
In the early weeks of life, very low birth weight (VLBW) infants experience intense laboratory blood sampling leading to clinically significant anemia and the need for red blood cell transfusion. Although controversial, treatment with recombinant human erythropoietin (EPO) and iron has been recommended to stimulate erythropoiesis; optimal dosing of EPO and iron is still uncertain.
Objectives:
To assess the validity of a four-quadrant diagnostic plot of iron availability (ferritin index) versus iron demand for erythropoiesis (reticulocyte hemoglobin content, CHr) for differentiating iron status in anemic VLBW infants.
Methods:
Study subjects were enrolled in a previously reported randomized controlled trial of clinically stable VLBW infants <31 weeks' gestation and <1,300 g at birth to receive 18 days of treatment with: group 1: oral iron; group 2: EPO + oral iron, and group 3: EPO + intravenous + oral iron.
Results:
At the end of treatment the ferritin index was significantly higher in both EPO groups compared to the control group. By day 18, CHr of the control group declined into the quadrant of the diagnostic plot characteristic of functional iron deficiency and anemia of chronic disease. Both EPO groups ended in the quadrants that are characteristic for latent iron deficiency and iron deficiency anemia, respectively.
Conclusions:
The diagnostic plot for differentiating anemia in VLBW infants may be an informative, clinically useful tool for iron status assessment under different physiologic and therapeutic erythropoietic states. Larger additional studies in difficult patient populations are needed before the clinical utility of this diagnostic procedure can be unequivocally confirmed.
